4basebio PLC (88Q.DE)
EUR 14.6
(0.0%)
EUR 14.6
(0.0%)
| Year | Eps | Eps Growth |
|---|---|---|
| 2023 | -0.62 GBP | -47.62% |
| 2022 | -0.42 GBP | -61.54% |
| 2021 | -0.26 GBP | -345.21% |
| 2020 | -0.06 GBP | -70.26% |
| 2019 | -0.03 GBP | 0.0% |
| Year | Eps | Eps Growth |
|---|---|---|
| 2024 Q2 | -0.53 EUR | 0.0% |
| 2023 Q4 | -0.38 EUR | -11.76% |
| 2023 FY | - GBP | -47.62% |
| 2023 Q2 | -0.34 EUR | -36.0% |
| 2022 Q4 | -0.25 EUR | -8.7% |
| 2022 FY | - GBP | -61.54% |
| 2022 Q2 | -0.23 EUR | -53.33% |
| 2021 Q2 | -0.16 EUR | -421.17% |
| 2021 FY | - GBP | -345.21% |
| 2021 Q4 | -0.15 EUR | 6.25% |
| 2020 Q2 | -0.03 EUR | 0.0% |
| 2020 FY | - GBP | -70.26% |
| 2020 Q4 | -0.03 EUR | 9.71% |
| 2019 FY | - GBP | 0.0% |
| Name | Eps | Eps Difference |
|---|---|---|
| BioNTech SE | 3.87 EUR | 116.021% |
| CureVac N.V. | -1.18 EUR | 47.458% |
| Biotest Aktiengesellschaft | 3.21 EUR | 119.315% |
| Biotest Aktiengesellschaft | 3.21 EUR | 119.315% |
| BRAIN Biotech AG | -0.38 EUR | -63.158% |
| Formycon AG | 4.76 EUR | 113.025% |
| Heidelberg Pharma AG | -0.44 EUR | -40.909% |
| Medigene AG | -0.66 EUR | 6.061% |